$Author Correction: Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial$

Paediatrics

Author Correction: Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial

November 16, 2024 November 16, 2024

Nat Med. 2024 Nov 15. doi: 10.1038/s41591-024-03404-w. Online ahead of print.

NO ABSTRACT

PMID:39548313 | DOI:10.1038/s41591-024-03404-w

John Joseph

JohnJAcademy.com

View all posts by John Joseph